정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
1787 | Completed | COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 | Respiratory Distress Syndrome, Adult | Drug: Veru-111 | Phase 2 | Veru Inc. | INDUSTRY | 39 | All | 18 Years | HonorHealth, Scottsdale, Arizona, United States Methodist Hospital, Saint Louis Park, Minnesota, United States Regions Hospital, Saint Paul, Minnesota, United States Inspira Medical Center, Vineland, New Jersey, United States Memorial Hermann Memorial City Hospital, Houston, Texas, United States |
1786 | Completed | COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy | SARS-CoV-2 | Drug: Methylene Blue and Photodynamic Therapy | Phase 1 | I.M. Sechenov First Moscow State Medical University, Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS) | OTHER | 60 | All | 18 Years ~ 90 Years | I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation |
1785 | Recruiting | Covid-19 Vaccination in Adolescents | Covid19 | Biological: Tozinameran Biological: CoronaVac |
Phase 2 | The University of Hong Kong | OTHER | 900 | All | 11 Years ~ 100 Years | Queen Mary Hospital, Hong Kong, Hong Kong, China |
1784 | Recruiting | COVID-19 Vaccination in Rheumatic Disease Patients | Osteoarthritis | Biological: mRNA COVD19 vaccine | Early Phase 1 | Mayo Clinic | OTHER | 100 | All | 18 Years | Mayo Clinic in Rochester, Rochester, Minnesota, United States |
1783 | Active, not recruiting | COVID-19 Vaccination of Immunodeficient Persons (COVAXID) | Covid19 | Biological: Comirnaty (COVID-19, mRNA vaccine) | Phase 4 | Karolinska University Hospital, Karolinska Institutet | OTHER | 540 | All | 18 Years | Karolinska University Hospital, Stockholm, Huddinge, Sweden |
1782 | Recruiting | COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults | Covid19 | Biological: hAd5-S-Fusion+N-ETSD vaccine | Phase 1 | ImmunityBio, Inc. | INDUSTRY | 35 | All | 18 Years ~ 50 Years | Khayelitsha Clinical Research Site, Khayelitsha, South Africa |
1781 | Active, not recruiting | COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers | COVID-19 | Biological: hAd5-S-Fusion+N-ETSD vaccine | Phase 1 | ImmunityBio, Inc. | INDUSTRY | 34 | All | 18 Years ~ 55 Years | Chan Soon - Shiong Institute for Medicine, El Segundo, California, United States Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States |